Cromolyn DSG effects in hyperkinetic and psychotic children with allergies.
Preliminary findings of an open trial of cromolyn in hyperkinetic and psychotic children indicates that the medication is useful, safe and well tolerated. Further controlled studies are suggested to determine the efficacy and indications of cromolyn in child psychiatry. Positive findings could clarify the biochemical mechanisms of hyperkinesis.
D000293:Adolescent; D000328:Adult; D002648:Child; D004205:Cromolyn Sodium / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006801:Humans; D006948:Hyperkinesis / Q000150:complications / Q000188:drug therapy*; D006967:Hypersensitivity / Q000150:complications* / Q000188:drug therapy; D008774:Methylphenidate / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy*; D011852:Radioallergosorbent Test
D008774:Methylphenidate; D004205:Cromolyn Sodium